Company Filing History:
Years Active: 1999
Title: Neil Shusterman: Innovator in Congestive Heart Failure Treatment
Introduction
Neil Shusterman, based in Wynnewood, Pennsylvania, is a notable inventor with a focus on innovative treatments in pharmaceuticals. With one patent to his name, he has made significant strides in the medical field, particularly concerning congestive heart failure.
Latest Patents
Shusterman's patent, titled "Use of Carbazole Compounds for the Treatment of Congestive Heart Failure," showcases his contribution to finding new therapeutic approaches for heart conditions. This pioneering work addresses an important health issue and demonstrates his dedication to improving patient outcomes.
Career Highlights
Shusterman has built an impressive career at Boehringer Mannheim Pharmaceuticals Corporation, which is now part of Roche. His work there emphasizes the importance of pharmaceutical innovation and highlights his role in advancing medication for heart-related ailments.
Collaborations
Throughout his career, Neil has collaborated with esteemed colleagues in the pharmaceutical industry, including Mary Ann Lukas-Laskey and Robert Ruffolo, Jr. These partnerships have bolstered his research efforts, leading to the development of impactful medical solutions.
Conclusion
In summary, Neil Shusterman's work serves as an inspiration for aspiring inventors and professionals in the medical field. His patent on carbazole compounds exemplifies the crucial role of innovation in enhancing treatments for congestive heart failure, underscoring his commitment to advancing healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.